Framatome and Korea Hydro & Nuclear Power are to assess the feasibility of producing medical isotope lutetium-177 in the Candu pressurised heavy water reactors at the Wolsong nuclear power plant in South Korea. Read this story
Framatome and Korea Hydro & Nuclear Power are to assess the feasibility of producing medical isotope lutetium-177 in the Candu pressurised heavy water reactors at the Wolsong nuclear power plant in South Korea. Read this story
More from www.world-nuclear-news.org